In order to provide you with a better browsing experience and to improve our site functionality, we use cookies and other tracking technologies. Detailed information on the use of cookies on our site and how to opt out is provided in our Cookie Policy. By clicking into any content on this site, you consent that we can store and access cookies and other tracking technologies as described in our Cookie Policy.

Singapore

News from Tokyo Headquarters

Display news for healthcare professionals

The news releases are issued by FUJIFILM Corporation in Japan.
Fujifilm makes no representation that products on these news releases are commercially available in all countries and regions.

Please note that contents in this website are current as of the date of the press announcement and may be subject to change without prior notice. Information in each release, including the product availability, specification, prices, contacts, are those at the time of publication.

Mar 31, 2023
Transfer of FUJIFILM Healthcare Systems’ electronic medical record and medical-receipt systems related business to PHC Holdings’ subsidiary
News Release Healthcare IT
Dec 20, 2022
Fujifilm Announces Asset Purchase Agreement with Inspirata, Inc. to acquire the company’s Digital Pathology Business
News Release M&A, Investment Healthcare IT
Dec 14, 2022
Fujifilm Invests in PhenoVista Biosciences from its Life Sciences Corporate Venture Capital Fund
News Release Regenerative Medicine M&A, Investment
Oct 6, 2022
Fujifilm to establish its first Bio-CDMO site in Japan
News Release Bio-CDMO CDMO M&A, Investment
Jun 30, 2022
Fujifilm to Invest USD 1.6 billion to enhance and expand its global offering of cell culture manufacturing services
News Release Bio-CDMO CDMO M&A, Investment
Apr 5, 2022
Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
News Release M&A, Investment Bio-CDMO CDMO
Mar 22, 2022
Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business
Amendment in relation to a return of domestic marketing rights for a product
News Release Pharmaceuticals
Sep 2, 2021
Transfer of FUJIFILM Toyama Chemical's Radiopharmaceutical Business to PeptiDream
News Release Pharmaceuticals
Aug 31, 2021
Launch of Therapeutic Radiopharmaceutical Product, Lutathera® Injection targeting neuroendocrine tumors in Japan (FUJIFILM Toyama Chemical)
News Release Pharmaceuticals
Jun 29, 2021
$850 Million USD (¥90 Billion Yen) investment in FUJIFILM Diosynth Biotechnologies to add additional development and manufacturing capacity
News Release M&A, Investment Bio-CDMO CDMO
Jun 23, 2021
Marketing Authorization Granted for Lutathera® Injection in Japan
- The first approval in Japan for peptide receptor radionuclide treatment drug, providing a new therapeutic option for neuroendocrine tumors (FUJIFILM Toyama Chemical)
News Release Pharmaceuticals
Mar 31, 2021
FUJIFILM Healthcare starts to operate as Fujifilm Group company
News Release M&A, Investment Healthcare IT X-ray Imaging Devices Ultrasound Devices
Mar 30, 2021
Fujifilm launches “FUJIFILM COVID-19 Ag Test”, a SARS-CoV-2 antigen rapid diagnostic test with a highly-sensitive detection technology based on silver halide amplification, in Europe
News Release In Vitro Diagnostics
Mar 19, 2021
Fujifilm Selects North Carolina as the Location to Build the Largest Cell Culture Biopharmaceutical CDMO Facility in North America
News Release M&A, Investment CDMO Bio-CDMO
Feb 18, 2021
Notice Concerning the Completion Timing for the Acquisition of Hitachi’s Diagnostic Imaging-related Business
News Release M&A, Investment Healthcare IT X-ray Imaging Devices Ultrasound Devices
Feb 15, 2021
Fujifilm Kyowa Kirin Biologics and Mylan EPD Announce Launch of “Adalimumab (Genetical Recombination) [Adalimumab Biosimilar 1]” in Japan
News Release Pharmaceuticals
Jan 29, 2021
Transfer of Shares in Japan Tissue Engineering Co., Ltd. to TEIJIN LIMITED
News Release Regenerative Medicine
Jan 14, 2021
Fujifilm and the Center for Advanced Biological Innovation and Manufacturing Announce 76 million USD in Funding for Manufacturing and Innovation Center
News Release M&A, Investment CDMO Bio-CDMO
Jan 7, 2021
Fujifilm to Invest Over 200 Billion yen (2 Billion USD) to Establish New Large-Scale Cell Culture Manufacturing Site for Biopharmaceuticals in the U.S.A.
News Release M&A, Investment CDMO Bio-CDMO
Jan 5, 2021
Fujifilm to invest $40 Million to Establish a New State-of-the-Art Viral Vector and Advanced Therapy Process Development and Manufacturing Facility
News Release M&A, Investment CDMO Bio-CDMO
1 / 2pages